Last $163.68 USD
Change Today +1.57 / 0.97%
Volume 847.0K
AGN On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - ALLERGAN INC (AGN)

Allergan Inc. to Report Q2, 2014 on Jul 21, 2014
CapIQ 07/21/2014 5:00 PM ET
Allergan Inc. to Report Q3, 2009 on October 29, 2009
CapIQ 07/21/2014 5:00 PM ET
Allergan Inc. to Report Q2, 2009 on July 31, 2009
CapIQ 07/21/2014 5:00 PM ET

2013 revenues at Allergan Inc. totaled $6.3B USD, while annual earnings equaled $4.77 per share.

Quarterly Earnings & Estimates - ALLERGAN INC (AGN)

Actuals vs. Estimates for ALLERGAN INC AGN

Allergan Inc.'s Quarterly Earnings

Allergan Inc. reported 2nd quarter 2014 earnings of $1.51 per share on 07/23/2014.

Annual Earnings & Estimates - ALLERGAN INC (AGN)

Actuals vs. Estimates for ALLERGAN INC AGN

Allergan Inc.'s Annual Earnings

Allergan Inc. reported annual 2013 earnings of $4.77 per share on 02/7/2014.

Quarterly Revenues - ALLERGAN INC (AGN)

Actuals vs. Estimates for ALLERGAN INC AGN

Allergan Inc.'s Quarterly Revenues

Allergan Inc. had 2nd quarter 2014 revenues of $1.9B USD. This bettered the $1.8B USD consensus of the 17 analysts covering the company. This was 16.7% above the prior year's 2nd quarter results.

Annual Revenues - ALLERGAN INC (AGN)

Actuals vs. Estimates for ALLERGAN INC AGN

Allergan Inc.'s Annual Revenues

Allergan Inc. had revenues for the full year 2013 of $6.3B USD. This was 8.5% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AGN:US $163.68 USD +1.57

AGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $226.98 USD +0.39
Astellas Pharma Inc ¥1,498 JPY -25.00
Regeneron Pharmaceuticals Inc $350.46 USD +3.53
Shire PLC 4,923 GBp +36.00
Sun Pharmaceutical Industries Ltd 855.25 INR 0.00
View Industry Companies
 

Industry Analysis

AGN

Industry Average

Valuation AGN Industry Range
Price/Earnings 37.5x
Price/Sales 7.2x
Price/Book 7.2x
Price/Cash Flow 34.7x
TEV/Sales 6.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.